51. Introduction to drug action Flashcards
what are the 4 receptor superfamilies:
ligand-gated ion-channel receptors,
G-protein-coupled receptors, kinase-linked receptors
nuclear receptors.
what are the four drug targets
receptors, ion channels, enzymes and transport/channel proteins.
what is a ligan
A substance that is bound to a protein.
what is affinity
the tendency of a ligand to bind to its receptor
what is an agonist
A ligand that binds to a receptor and alters the receptor state resulting in a biological response.
what is an antagonist
A drug that reduces the action of another drug, generally an agonist. Many antagonists act at the same receptor macromolecule as the agonist.
what is a partial agonist
An agonist that cannot elicit as large an effect (even with 100% receptor occupancy) as can another agonist acting through the same receptors in the same tissue
what is efficacy
the tendency for an agonist to activate the receptor state resulting in a biological response
and the maximum response achievable from a drug
what is - Drug Potency -
the concentration or amount needed to produce a desired effect (e.g., EC50).
describe - Drug selectivity –
the degree to which a drug has affinity for its intended target to the exclusion of other (‘off’) targets.
The greater the selectivity for the intended target, the greater the likelihood that the drug will evoke the intended physiological mode of action and less the likelihood that the drug will evoke an adverse effect by acting at ‘off’ targets.
Dose
- a specified quantity of drug administered once or at stated intervals. Doses can be relative to body weight (e.g., mg/kg).
From the dose-response curve, we can estimate the …..
ED50 (note, not the EC50!).
what is drug specificity
- To be useful, a drug must act selectively for a specific receptor, i.e., it must have a high degree of specificity for the binding site of the receptor.
The Relationship Between Ligand Concentration and Receptor Occupancy. What is the equation.
Hill- Langmuir equation
what is the EC50
Concentration of agonist that elicits half maximal effect